Join us Thursday 4/24 at 2pm Central Time, as we focus on the valuation range for Ford (F). Register here. HIDE

Keryx Biopharmaceuticals (KERX)

Add to Watchlists
Create an Alert
13.80 -0.43  -3.02% NASDAQ Apr 23, 4:59PM BATS Real time Currency in USD
View Full Chart
KERX Price Chart
View All Events

KERX Events

Date Type Description
Mar 13 Misc Q4 2013 Keryx Biopharmaceuticals, Inc. Earnings Conference Call
Mar 13 Earnings Q4 2013 Keryx Biopharmaceuticals, Inc. Earnings Results. Estimate: -0.19.
Nov 05 Misc Q3 2013 Keryx Biopharmaceuticals, Inc. Earnings Conference Call
Nov 04 Earnings Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2013 Financial Results. Estimate: -0.14.
Aug 01 Misc Q2 2013 Keryx Biopharmaceuticals, Inc. Earnings Conference Call
Aug 01 Earnings Results for the Second Quarter Ended June 30, 2013. Estimate: -0.09.
Jun 18 Misc AGM Event for Keryx Biopharmaceuticals Inc
May 08 Misc Q1 2013 Keryx Biopharmaceuticals, Inc. Earnings Conference Call
May 08 Earnings Q1 2013 Keryx Biopharmaceuticals, Inc. Earnings Conference Call. Estimate: -0.02.
View All Performance Charts

KERX Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Keryx Biopharmaceuticals is up 65.87% over the last year vs S&P 500 Total Return up 22.59%, Actelion up 71.93%, and Alexion Pharmaceuticals up 68.04%.

Get Quote for

PDF Report for KERX

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download KERX Pro Report PDF
Advertisement

Portfolio Strategies Featuring KERX

Did Keryx Biopharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

KERX Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: New York
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Keryx Biopharmaceuticals, Inc., is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of renal disease. It is developing ZerenexTM an oral, ferric iron-based compound.

Recent Quotes

Symbol Price Chg Chg % Market Cap
KERX 13.80 -0.43 -3.02% 1.255B
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.